pubmed.ncbi.nlm.nih.gov
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies...
IFN-I and IFN-III immunity in the nasal mucosa is poorly characterized during SARS-CoV-2 infection. We analyze the nasal IFN-I/III signature, namely the expression of ISGF-3-dependent IFN-stimulated...